J. Barbet

发表

Treatment of metastatic medullary thyroid cancer with vandetanib: need to stratify patients on basis of calcitonin doubling time.

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated With Macrophage Alternative Activation

F. Leturcq, I. Desguerre, J. Barbet, 2009, Journal of neuropathology and experimental neurology.

Effect of Patient Morphology on Dosimetric Calculations for Internal Irradiation as Assessed by Comparisons of Monte Carlo Versus Conventional Methodologies

Jacques Barbet, Ludovic Ferrer, Antigoni Divoli, 2009, Journal of Nuclear Medicine.

ENHANCED IN VIVO TARGETING OF AN ASYMMETRIC BIVALENT HAPTEN ANTIBODY CONJUGATE COCKTAILS TO DOUBLE-ANTIGEN-POSITIVE MOUSE B CELLS WITH MONOCLONAL

E. Gautherot, J. Barbet, J. L. Doussal, 1991 .

Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence

C. Bodet-Milin, F. Kraeber-Bodéré, T. Carlier, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.

Jacques Barbet, Françoise Roquet, Daniel Baty, 2007, Molecular immunology.

Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT

C. Bodet-Milin, F. Kraeber-Bodéré, T. Carlier, 2013, EJNMMI Research.

Innovative Radiopharmaceuticals in Oncology and Neurology

D. Guilloteau, F. Kraeber-Bodéré, J. Barbet, 2017 .

A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation

F. Nguyen, J. Barbet, C. Hindorf, 2014, The Journal of Nuclear Medicine.

Improvement of Radioimmunotherapy Using Pretargeting

C. Bodet-Milin, F. Kraeber-Bodéré, J. Chatal, 2013, Front. Oncol..

Scanning tunneling microscopy of monoclonal immunoglobulin G

Jacques Barbet, Jean-Paul Chauvin, J. Chauvin, 1994 .

ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine

T. Carlier, J. Chatal, J. Barbet, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

F. Borson‐Chazot, F. Kraeber-Bodéré, J. Chatal, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.

J. Chatal, D. Goldenberg, J. Barbet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Monoclonal antibody covalently coupled to liposomes: specific targeting to cells.

L. Leserman, J. Barbet, P. Machy, 1981, Journal of supramolecular structure and cellular biochemistry.

Cell membrane, but not circulating, carcinoembryonic antigen is linked to a phosphatidylinositol-containing hydrophobic domain.

G. Rougon, J. Barbet, P. Malapert, 1988, Biochemical and biophysical research communications.

Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat.

J. Barbet, J. Treluyer, G. Pons, 2001, Toxicology and applied pharmacology.

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

O. Boerman, J. Chatal, D. Goldenberg, 2007, Update on cancer therapeutics.

Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates

J. Barbet, R. Maurice, D. Tezé, 2017, Scientific Reports.

Acquisition setting optimization and quantitative imaging for 124 I studies with the Inveon

T. Carlier, J. Barbet, C. Hindorf, 2012 .

dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system

T. Carlier, J. Barbet, C. Hindorf, 2012, EJNMMI Research.

Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains.

G. Butler-Browne, V. Mouly, M. Fiszman, 1994, Developmental biology.

Recent advances in pretargeted radioimmunotherapy.

J. Barbet, A. Gruaz-Guyon, O. Raguin, 2005, Current medicinal chemistry.

Pretargeting in the context of theranostics and companion diagnostics in nuclear oncology

J. Barbet, 2018, Clinical and Translational Imaging.

Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2016, The Journal of Nuclear Medicine.

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

F. Borson‐Chazot, F. Kraeber-Bodéré, S. Bardet, 2012, The Journal of Nuclear Medicine.

Pharmacokinetic and tumor‐seeking properties of recombinant and nonrecombinant anti‐carcinoembryonic antigen antibody fragments

M. Dorvillius, J. Barbet, A. Pèlegrin, 2002, International journal of cancer.

Weak acid-induced release of liposome-encapsulated carboxyfluorescein.

L. Leserman, J. Barbet, A. Truneh, 1984, Biochimica et biophysica acta.

Antibody-Bearing Liposomes as Probes of Receptor-Mediated Endocytosis

L. Leserman, J. Barbet, A. Truneh, 1984 .

Drug transfer into lymphoblasts mediated by liposomes bound to distinct sites on H-2 encoded I-A, I-E, and K molecules.

L. Leserman, J. Barbet, M. Pierres, 1982, Journal of immunology.

Cell-specific drug transfer from liposomes bearing monoclonal antibodies

L. Leserman, J. Barbet, P. Machy, 1981, Nature.

TestDose: Software for creating dosimetry problems

Jacques Barbet, Erin McKay, Ludovic Ferrer, 2009 .

Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide

D. Goldenberg, J. Barbet, M. Bardiès, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Use of Monoclonal Antibodies to Detect Metastases of Solid Tumors in Lymph Nodes

J. Weinstein, D. Covell, J. Barbet, 1985 .

Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease.

E. Denamur, A. Laquérriere, H. Le Nagard, 2010, Kidney international.

Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.

V. Rohmer, F. Kraeber-Bodéré, S. Bardet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model

John O. Prior, G. Coukos, J. Barbet, 2021, Pharmaceutics.

Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine

F. Kraeber-Bodéré, J. Barbet, 2014, Front. Med..

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer

M. Campone, F. Kraeber-Bodéré, D. Goldenberg, 2020, The Journal of Nuclear Medicine.

Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasies

J. Barbet, S. Huclier-Markai, 2019, Pharmaceutical statistics.

Radiolytic Corrosion of Uranium Dioxide: Role of Molecular Species

J. Barbet, B. Humbert, G. Blain, 2014 .

RADIOLYTIC CORROSION OF GRAIN BOUNDARIES ONTO THE UO2 TRISO PARTICLE SURFACE

J. Barbet, G. Blain, J. Vandenborre, 2012 .

New Advances in Radioimmunotherapy for the Treatment of Cancers

C. Bodet-Milin, F. Kraeber-Bodéré, T. Carlier, 2020, Cancer Immunology.

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma

C. Bodet-Milin, F. Kraeber-Bodéré, J. Barbet, 2013, Front. Oncol..

Radioactive antibodies: Selective targeting and treatment of cancer and other diseases

J. Chatal, D. Goldenberg, J. Barbet, 2007, Applied Radiology.

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

E. Gautherot, J. Barbet, E. Rouvier, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors.

J. Chatal, J. Barbet, M. Chérel, 2009, Journal of cancer research and therapeutics.

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

W. McBride, J. Chatal, D. Goldenberg, 2002, Molecular cancer therapeutics.

Which radionuclides will nuclear oncology need tomorrow?

F. Gauché, J. Chatal, J. Barbet, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients

O. Couturier, C. Bodet-Milin, F. Kraeber-Bodéré, 2015, Front. Med..

Radioimmunoconjugates for the treatment of cancer.

C. Bodet-Milin, F. Kraeber-Bodéré, T. Carlier, 2014, Seminars in oncology.

Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy

J. Chatal, J. Barbet, M. Bourgeois, 2012 .

Alpha particles more promising than toxins?

J. Chatal, J. Barbet, M. Chérel, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.

P. Chevallier, M. Béné, X. Thomas, 2015, The Lancet. Haematology.

In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.

E. Gautherot, J. Barbet, M. Delaage, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Syndecan-1 Antigen, a Promising New Target for Triple-negative Breast Cancer Immuno-pet and Radioimmunotherapy. a Preclinical Study on Mda-mb-468 Xenograft Tumors

F. Kraeber-Bodéré, J. Barbet, D. Loussouarn, 2022 .

Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2002, Molecular cancer therapeutics.

Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2012, Tumor Biology.

Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.

B. Dupas, F. Kraeber-Bodéré, S. Bardet, 2005, The Journal of clinical endocrinology and metabolism.

Thy-1 immunolabeled thymocyte microdomains studied with the atomic force microscope and the electron microscope.

J. Chauvin, J. Barbet, J. Thimonier, 1997, Biophysical journal.

Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA‐A2/Mage3 complex density using a high‐affinity TCR like monoclonal antibody

M. Bonneville, J. Barbet, A. Devys, 2005, European journal of immunology.

[Immunotargeting of tumors: state of the art and prospects in 2000].

B. Robert, L. Leserman, F. Buchegger, 2000, Bulletin du cancer.

A pretargeting system for tumor PET imaging and radioimmunotherapy

C. Bodet-Milin, F. Kraeber-Bodéré, J. Chatal, 2015, Front. Pharmacol..

Radioiodinated and astatinated NHC rhodium complexes: synthesis.

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2014, Nuclear medicine and biology.

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

E. Gautherot, J. Barbet, A. Gruaz-Guyon, 1990, Cancer research.

Immunocytochemical characterisation of two generations of fibers during the development of the human quadriceps muscle

G. Butler-Browne, J. Barbet, L. Thornell, 1991, Mechanisms of Development.

Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer

E. Gautherot, A. Mishra, J. Chatal, 2000, Annals of nuclear medicine.

Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.

E. Gautherot, J. Chatal, J. Barbet, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches

C. Bailly, C. Bodet-Milin, F. Kraeber-Bodéré, 2019, Front. Med..

Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial

V. Rohmer, O. Couturier, C. Bodet-Milin, 2016, The Journal of Nuclear Medicine.

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.

E. Gautherot, J. Chatal, J. Barbet, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy.

E. Gautherot, W. Rostène, J. Barbet, 1997, Bioconjugate chemistry.

Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.

J. Barbet, M. Delaage, J. Le Doussal, 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.

W. Mcbride, G. Griffiths, D. Goldenberg, 2000, Bioconjugate chemistry.

ALPHA EMITTING RADIONUCLIDES AND RADIOPHARMACEUTICALS FOR THERAPY

J. Barbet, M. Chérel, 2014 .

Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.

J. Barbet, C. Cutler, S. Huclier-Markai, 2013, Current topics in medicinal chemistry.

Extraction of astatine-211 in diisopropylether (DIPE)

J. Barbet, T. Sauvage, M. Chérel, 2009 .

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2005, The Journal of clinical endocrinology and metabolism.

Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten.

F. Kraeber-Bodéré, E. Gautherot, J. Chatal, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions.

J. Barbet, R. Rahmani, J. Cano, 1983, Clinica chimica acta; international journal of clinical chemistry.

Mechanisms of Cell Sensitization to α Radioimmunotherapy by Doxorubicin or Paclitaxel in Multiple Myeloma Cell Lines

J. Chatal, J. Barbet, C. Apostolidis, 2005, Clinical Cancer Research.

Plasticity of human satellite cells

G. Butler-Browne, V. Mouly, J. Barbet, 1993, Neuromuscular Disorders.

Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety

John O. Prior, J. Barbet, S. Gnesin, 2021, Cancers.

Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.

J. Weinstein, D. Covell, J. Barbet, 1987, Journal of immunology.

Regional delivery of monoclonal antitumor antibodies: detection and possible treatment of lymph node metastases.

J. Weinstein, D. Covell, J. Barbet, 1986, Progress in clinical and biological research.

IMPACT OF WATER RADIOLYSIS ON URANIUM DIOXIDE CORROSION

J. Barbet, G. Blain, J. Vandenborre, 2012 .

Pretargeting for imaging and therapy in oncological nuclear medicine

C. Bailly, C. Bodet-Milin, F. Kraeber-Bodéré, 2017, EJNMMI Radiopharmacy and Chemistry.

Digestive Endoscopy in Neonates

C. Dupont, D. De boissieu, J. Barbet, 2005, Journal of pediatric gastroenterology and nutrition.

High‐intensity focused ultrasound in the treatment of postpartum hemorrhage: an animal model

Y. Ville, J. Barbet, B. De Keersmaecker, 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Bifunctional antibodies for radioimmunotherapy.

E. Gautherot, J. Chatal, J. Barbet, 1995, Hybridoma.

The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?

J. Chatal, J. Barbet, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Preliminary study of the metal binding site of an anti-DTPA-indium antibody by equilibrium binding immunoassays and immobilized metal ion affinity chromatography.

J. Barbet, J. Le Doussal, Mookambeswaran Vijayalakshmi, 1995, Bioconjugate chemistry.

Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy.

G. Butler-Browne, V. Mouly, J. Barbet, 1997, Human gene therapy.

Quantitation of adriamycin in plasma and urine: comparative study of radioimmunoassay and high-performance liquid chromatography methods.

J. Barbet, R. Rahmani, J. Cano, 1983, Journal of pharmaceutical and biomedical analysis.

Breathing dry air causes acute epithelial damage and inflammation of the guinea pig trachea.

J. Barbet, M. Chauveau, A. Lockhart, 1988, Journal of applied physiology.

Role of ATP-Dependent Potassium Channels in Pulmonary Vascular Tone of Fetal Lambs With Congenital Diaphragmatic Hernia

Y. Aigrain, J. Barbet, A. Dinh-Xuan, 2006, Pediatric Research.

Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods?

W. McBride, J. Chatal, D. Goldenberg, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia

M. Dorvillius, L. Sorkin, M. Diccianni, 2014, PloS one.

Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

F. Kraeber-Bodéré, A. Devillers, J. Chatal, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo 212Pb/212Bi generator using indium-DTPA-tagged liposomes

J. Barbet, E. Botosoa, G. Montavon, 2011 .

Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.

J. Talbot, J. Barbet, A. Prignon, 2011, Bioconjugate chemistry.

Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.

J. Talbot, P. Forgez, A. Couvelard, 2019, Molecular pharmaceutics.

Bispecffic Monoclonal Antibody-Mediated Targeting of an Indium-ill-Labeled DTPA Dimer to Primary Colorectal Tumors: Pharmacokinetics , Biodistribution, Scintigraphy and Immune Response

E. Gautherot, J. Barbet, A. Gruaz-Guyon, 2006 .

Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen

F. Paris, J. Barbet, A. Faivre-Chauvet, 2007, Clinical Cancer Research.

The ARRONAX project.

J. Chatal, J. Barbet, F. Haddad, 2011, Current radiopharmaceuticals.

Radiolabelling of proteins with stabilised hypervalent astatine-211: Feasability and stability

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2011 .

Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction.

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2008, Journal of labelled compounds & radiopharmaceuticals.

Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.

W. Rostène, J. Barbet, A. Gruaz-Guyon, 2002, Bioconjugate chemistry.

Influence of cytokinins on the biosynthesis of light-harvesting chlorophyll ab proteins in tobacco cell suspensions: Detection by radioimmunological assay

J. Barbet, M. Axelos, C. Péaud-Lenoël, 1984 .

Antigen-Specific Cells Dendritic Cells and Surface Ig of of Targeted to Various Cell Surface Molecules Efficient Presentation of Multivalent Antigens

L. Leserman, J. Barbet, K. Serre, 1998 .

Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy.

J. Barbet, A. Gruaz-Guyon, O. Raguin, 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.

A. de Roquancourt, P. Cattan, W. Rostène, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A simple and efficient method to label l-fucose

J. Barbet, A. Faivre-Chauvet, A. Loussouarn, 2006 .

Evidence that murine hematopoietic cell subset marker J11d is attached to a glycosyl‐phosphatidylinositol membrane anchor

G. Rougon, J. Barbet, P. Naquet, 1987, European journal of immunology.

Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2007, International journal of pharmaceutics.

High-Activity Radio-Iodine Labeling of Conventional and Stealth Liposomes

J. Barbet, L. Morandeau, A. Faivre-Chauvet, 2006, Journal of liposome research.

A labeled neutral endopeptidase inhibitor as a potential tool for tumor diagnosis and prognosis.

A. Romieu, B. Roques, J. Barbet, 2005, Angewandte Chemie.

Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children

G. Butler-Browne, V. Mouly, J. Barbet, 2000, Neuromuscular Disorders.

Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails.

E. Gautherot, J. Barbet, M. Delaage, 1991, Journal of immunology.

Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2010, Cancer.

Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.

J. Barbet, S. Huclier-Markai, F. Haddad, 2014, Nuclear medicine and biology.

Medullary Thyroid Carcinoma

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2012 .

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody

J. Chatal, D. Goldenberg, J. Barbet, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

The four populations of myoblasts involved in human limb muscle formation are present from the onset of primary myotube formation.

G. Butler-Browne, V. Mouly, J. Barbet, 1999, Journal of cell science.

A novel T cell-activating molecule (THAM) highly expressed on CD4-CD8- murine thymocytes.

H. Macdonald, J. Barbet, P. Naquet, 1988, Journal of immunology.

Behavior of heptavalent technetium in sulfuric acid under α-irradiation: structural determination of technetium sulfate complexes by X-ray absorption spectroscopy and first principles calculations.

R. Essehli, M. Schlegel, J. Barbet, 2014, The journal of physical chemistry. A.

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

F. Kraeber-Bodéré, E. Gautherot, M. Fiche, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pretargetted imaging of colorectal cancer recurrences using an 111In‐labelled bivalent hapten and a bispecific antibody conjugate

J. Chatal, J. Barbet, E. Rouvier, 1994, Nuclear medicine communications.

Induction of IL-2 receptor expression in vivo: response to concanavalin A.

J. Weinstein, E. Shevach, R. Kroczek, 1988, Cellular immunology.

45,X/46,XY Mosaicism: Report of 27 Cases

J. Barbet, J. Chaussain, A. Lebbar, 1999, Pediatrics.

Radiolabeled antibodies for cancer imaging and therapy.

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2012, Methods in molecular biology.

Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody.

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2014, Nuclear medicine and biology.

Protein Phosphorylation Induced by Phorbol Esters and Cyclic AMP in Anterior Pituitary Cells: Possible Role in Adrenocorticotropin Release and Synthesis

G. Rougon, J. Barbet, T. Reisine, 1989, Journal of neurochemistry.

Skeletal Muscle and Peripheral Nerves

J. Barbet, 1993 .

Monoclonal antibodies to antitumor Vinca alkaloids: thermodynamics and kinetics.

P. Pontarotti, J. Barbet, R. Rahmani, 1985, Molecular immunology.

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

J. Barbet, A. Iliadis, R. Rahmani, 1987, Cancer research.

Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).

J. Barbet, R. Rahmani, J. Cano, 1984, Cancer research.

Therapy of medullary thyroid cancer

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2007 .

Food-induced alterations of intestinal permeability in children with cow's milk-sensitive enteropathy and atopic dermatitis.

C. Dupont, J. Barbet, P. Molkhou, 1989, Journal of pediatric gastroenterology and nutrition.

Binding Activities and Antitumor Properties of a NewMouse / Human Chimeric Antibody Specific for GD 2

Fran, J. Barbet, A. Faivre-Chauvet, 2007 .

Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats

J. Barbet, R. Rahmani, J. Cano, 2004, Cancer Chemotherapy and Pharmacology.

Isolation and characterization of a novel glycosyl-phosphatidylinositol-anchored glycoconjugate expressed by developing neurons.

G. Rougon, C. Faivre-Sarrailh, J. Barbet, 1992, European journal of biochemistry.

Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code

M Bardiès, I Aubineau-Lanièce, A Bitar, 2006, Physics in medicine and biology.

The birth of a monstrous child throughout history: the example of anencephaly between the Egyptian New Empire and the 21st century.

J. Fischer, J. Barbet, 2014, Medicina nei secoli.

Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death.

L. Sabatier, F. Paris, J. Barbet, 2007, Cancer research.

LET effects on the hydrogen production induced by the radiolysis of pure water

R. Essehli, J. Barbet, G. Blain, 2013 .

Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes

J. Bolard, J. Barbet, P. Yeni, 1990, Antimicrobial Agents and Chemotherapy.

Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate.

L. Leserman, J. Barbet, P. Machy, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

Jacques Barbet, John N. Weinstein, J. Weinstein, 1980, Nature.

Effect of Metronidazole Resistance on Bacterial Eradication of Helicobacter pylori in Infected Children

C. Dupont, J. Barbet, N. Kalach, 1998, Antimicrobial Agents and Chemotherapy.

A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity

F. Paris, J. Barbet, T. Chaumette, 2011, PloS one.

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.

J N Weinstein, J. Weinstein, D. Covell, 1986, Cancer research.

Two novel phospholipid-linked mouse thymocyte surface molecules released by phosphatidylinositol-specific phospholipase C.

J. Barbet, M. Pierres, 1987, Molecular immunology.

Thy-1 solubilization from mouse T cells by phosphatidylinositol-specific phospholipase C: biochemical and antigenic characterization.

J. Barbet, M. Pierres, 1987, Annales de l'Institut Pasteur. Immunology.

Meiotic studies of infertile men in case of non-obstructive azoospermia with normal karyotype and no microdeleted Y-chromosome precise the clinical couple management.

J. Barbet, E. Erdei, M. North, 2004, Annales de genetique.

Improved realism of hybrid mouse models may not be sufficient to generate reference dosimetric data.

Manuel Bardiès, Jacques Barbet, Jean-Pierre Pouget, 2013, Medical physics.

Impact of Mouse Model on Pre-Clinical Dosimetry in Targeted Radionuclide Therapy

Jacques Barbet, Manuel Bardies, Pierre-Olivier Kotzki, 2009 .

A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP)

A Lisbona, J. Barbet, M. Bardiès, 2007, Physics in medicine and biology.

Mechanisms of degradation of 2'-5' oligoadenylates.

J. Barbet, M. Trujillo, H. Cailla, 1988, Biochimie.

Endocytosis of liposomes bound to cell surface proteins measured by flow cytofluorometry.

L. Leserman, J. Barbet, A. Truneh, 1983, The Biochemical journal.

Myosin heavy and light chain expression during human skeletal muscle development and precocious muscle maturation induced by thyroid hormone

G. Butler-Browne, J. Barbet, L. Thornell, 2004, Anatomy and Embryology.

New insights into the molecular mechanisms of stress

G. Rougon, J. Barbet, T. Reisine, 1986, Trends in Neurosciences.

Liposome delivery of cyclic AMP-dependent protein kinase inhibitor into intact cells: specific blockade of cyclic AMP-mediated adrenocorticotropin release from mouse anterior pituitary tumor cells

G. Rougon, J. Barbet, T. Reisine, 1986, The Journal of cell biology.

Defective satellite cells in congenital myotonic dystrophy.

C. Junien, G. Butler-Browne, V. Mouly, 2001, Human molecular genetics.

Immuno-PET for Clinical Theranostic Approaches

C. Bailly, C. Bodet-Milin, F. Kraeber-Bodéré, 2016, International journal of molecular sciences.

Immaturity of muscle fibers in the congenital form of myotonic dystrophy: Its consequences and its origin

J. Barbet, R. Wehrlé, S. Dancea, 1988, Journal of the Neurological Sciences.

Is the pterygopalatomaxillary suture (sutura sphenomaxillaris) a growing suture in the fetus?

C. Vacher, J. Barbet, J. Onolfo, 2010, Surgical and Radiologic Anatomy.

Structural requirements for recognition of vasopressin by antibody; thermodynamic and kinetic characteristics of the interaction.

J. Barbet, M. Delaage, A. Cupo, 1981, Molecular immunology.

Distinct Features of Upper Gastrointestinal Endoscopy in the Newborn

C. Dupont, D. De boissieu, J. Barbet, 1994, Journal of pediatric gastroenterology and nutrition.

In vitro killing of neuroblastoma cells by neutrophils derived from granulocyte colony-stimulating factor-treated cancer patients using an anti-disialoganglioside/anti-Fc gamma RI bispecific antibody

W. Fridman, S. Moutel, J. Barbet, 1995 .

In vitro killing of neuroblastoma cells by neutrophils derived from granulocyte colony-stimulating factor-treated cancer patients using an anti-disialoganglioside/anti-Fc gamma RI bispecific antibody.

W. Fridman, S. Moutel, J. Barbet, 1995, Blood.

[Decreased intraepithelial lymphocytes in the intestinal mucosa in children with malnutrition and parasitic infections].

J. Barbet, D. Gendrel, M. Kombila, 1992, Annales de pediatrie.

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer

F. Kraeber-Bodéré, J. Chatal, D. Goldenberg, 2009, Current oncology.

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.

D Huglo, D. Huglo, S. Bardet, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[Rhabdomyosarcomas discovered in newborn infants. Study of markers of muscle differentiation].

G. Butler-Browne, V. Mouly, J. Barbet, 1989, Annales de pathologie.

Phosphatidylinositol is involved in the membrane attachment of NCAM‐120, the smallest component of the neural cell adhesion molecule.

J. Barbet, G. Gennarini, C. Goridis, 1986, The EMBO journal.

Improvement of Dysphagia following Cricopharyngeal Myotomy in a Group of Elderly Patients

G. Butler-Browne, J. Barbet, S. Périé, 1995, The Annals of otology, rhinology, and laryngology.

Intervertebral disc degeneration: the role of the mitochondrial pathway in annulus fibrosus cell apoptosis induced by overload.

John Y-J Shyy, Jeffrey C Lotz, J. Lotz, 2004, The American journal of pathology.

Satellite Cell Proliferation : Starting Point and Key Steps to Regeneration and Cell-Mediated Gene Therapy

R. Cooper, G. Butler-Browne, V. Mouly, 2007 .

[The placenta and trisomies 13, 18, 21].

J. Barbet, H. Copin, A. Choiset, 1989, Journal de gynecologie, obstetrique et biologie de la reproduction.

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)

T. Cooper, A. Roses, S. Tapscott, 2000, Neurology.

Transition of myosin isozymes during development of human masseter muscle. Persistence of developmental isoforms during postnatal stage.

G. Butler-Browne, J. Barbet, C. Laurent‐Winter, 1990, Development.

Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA–In)

J. Barbet, A. Faivre-Chauvet, S. Gouard, 2015, Front. Med..

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO--a selected review.

J. Barbet, A. Faivre-Chauvet, M. Chérel, 2011, Nuclear medicine review. Central & Eastern Europe.

Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study

V. Rohmer, O. Couturier, C. Bodet-Milin, 2021, The Journal of Nuclear Medicine.

Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging

A. Sézeur, C. Chastang, J. Talbot, 2007, Clinical Cancer Research.

Induction with a synthetic peptide of antibodies to HLA class I C-terminal intracytoplasmic region.

G. Rougon, J. Barbet, B. Jordan, 1984, Molecular immunology.

[The first appearance of Meckel's cartilage in the fetus].

J. Barbet, L. Fonzi, C. Bontemps, 2001, Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie.

Cell Tracking in Cancer Immunotherapy

F. Kraeber-Bodéré, J. Barbet, A. Faivre-Chauvet, 2020, Frontiers in Medicine.

What can be expected from nuclear medicine tomorrow?

F. Kraeber-Bodéré, J. Chatal, J. Barbet, 2008, Cancer biotherapy & radiopharmaceuticals.

Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial.

I. Soubeyran, P. Moreau, R. Gressin, 2017, The Lancet. Haematology.

Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.

J. Grivel, L. Leserman, J. Barbet, 1998, Journal of immunology.

Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections.

J. Barbet, R. Rahmani, J. Cano, 1984, European journal of cancer & clinical oncology.

Clinical pharmacokinetics of vindesine infusion.

J. Barbet, R. Rahmani, J. Cano, 1985, Cancer treatment reports.

Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens.

E. Shevach, R. Kroczek, J. Barbet, 1987, Journal of immunology.

Methotrexate-vindesine association in leukemia: Pharmacokinetic study

J. Barbet, D. Maraninchi, J. Cano, 1985, Medical oncology and tumor pharmacotherapy.

Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes.

G. Rougon, J. Barbet, T. Reisine, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Connections of the bladder plate and bladder neck with the bony pelvis in a fetus with classic bladder exstrophy.

J. Barbet, A. Wakim, 2002, Urology.

Rectosigmoidoscopic Findings During Isolated Rectal Bleeding in the Neonate

C. Dupont, J. Barbet, M. Voyer, 1987, Journal of pediatric gastroenterology and nutrition.

Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen–Expressing Medullary Thyroid Cancer Xenograft

A. Bikfalvi, F. Paris, C. Bodet-Milin, 2010, Journal of Nuclear Medicine.

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma

F. Paris, C. Bodet-Milin, F. Kraeber-Bodéré, 2010, Cancer.

Comparative targeting of human colon‐carcinoma multicell spheroids using one‐ and two‐step (bispecific antibody) techniques

E. Gautherot, J. Chatal, J. Barbet, 1996, International journal of cancer.

The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody

J. Barbet, A. Faivre-Chauvet, E. Frampas, 2011, Nuclear medicine communications.

Is There an Interest to Use Deuteron Beams to Produce Non-Conventional Radionuclides?

J. Barbet, S. Huclier-Markai, V. Bossé, 2015, Front. Med..

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model

J. Barbet, F. Bruchertseifer, L. Ferrer, 2015, Front. Med..

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Jacques Barbet, Ludovic Ferrer, Caroline Rousseau, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.

J. Douillard, P. Moreau, D. Moro, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

M Bardiès, F. Kraeber-Bodéré, S. Bardet, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pretargeting with the affinity enhancement system for radioimmunotherapy.

F. Kraeber-Bodéré, E. Gautherot, J. Chatal, 1999, Cancer biotherapy & radiopharmaceuticals.

Targeting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens. Results and clinical perspectives.

E. Gautherot, J. Barbet, E. Rouvier, 1997, Hormone research.

Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.

M Bardiès, A Lisbona, J. Douillard, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tumor Immunotargeting Using Innovative Radionuclides

C. Bodet-Milin, F. Kraeber-Bodéré, T. Carlier, 2015, International journal of molecular sciences.

Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: Impact of DNA repair

Jacques Barbet, Catherine Massart, Nicolas Foray, 2008, International journal of radiation biology.

Accuracy of AFM measurements of the contour length of DNA fragments adsorbed on mica in air and in aqueous buffer.

Jacques Barbet, M. Marilley, J. Barbet, 2002, Ultramicroscopy.

Applications of Near-field Microscopes to Cell Biology

J. Barbet, J. Thimonier, J. Rocca-Serra, 1996 .

Inhibition of the catalytic properties of Staphylococcus aureus nuclease by monoclonal antibodies

D. Covell, D. Sachs, J. Barbet, 1987, Molecular and Cellular Biochemistry.

Evaluation of a serological test for diagnosis ofHelicobacter pylori infection in children

C. Dupont, J. Barbet, N. Kalach, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

F. Borson‐Chazot, F. Kraeber-Bodéré, S. Bardet, 2007, The Journal of clinical endocrinology and metabolism.

Intracellular uptake and catabolism of anti‐IgM antibodies and BI‐specific antibody‐targeted hapten by B‐lymphoma cells

J. Barbet, E. Rouvier, A. Gruaz-Guyon, 1995, International journal of cancer.

[Intrication of smooth and striated muscle during the development of the ano-rectal sphincter].

C. Dupont, J. Barbet, D. Bourdelat, 1999, Morphologie : bulletin de l'Association des anatomistes.

The archaeal “7 kDa DNA-binding” proteins: extended characterization of an old gifted family

F. Pecorari, J. Barbet, G. Béhar, 2016, Scientific Reports.

Cardiac valve involvement in ADAR-related type I interferonopathy

Y. Crow, S. Rahman, A. Giardini, 2019, Journal of Medical Genetics.

INDUCTION OF IL‐2 RECEPTOR EXPRESSION IN VIVO RESPONSE TO ALLOGENEIC CELLS

E. Shevach, R. Kroczek, J. Barbet, 1987, Transplantation.

Scanning tunneling microscopy of colloidal gold beads

J. Chauvin, J. Barbet, J. Thimonier, 1993 .

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.

E. Gautherot, J. Barbet, E. Rouvier, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Translational molecular imaging in exocrine pancreatic cancer

B. Cornelissen, M. de Jong, J. Barbet, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Endocytosis of HLA and H‐2 molecules on transformed murine cells measured by fluorescence dequenching of liposome‐encapsulated carboxyfluorescein.

F. Lemonnier, L. Leserman, J. Barbet, 1983, The EMBO journal.

Expression of developmentally regulated muscle proteins in rhabdomyosarcomas.

C. Meijer, G. Butler-Browne, J. Barbet, 1994, The American journal of pathology.

Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients

J. Barbet, D. Maraninchi, J. Cano, 2004, Cancer Chemotherapy and Pharmacology.

Generation of fluorescently labeled tracers – which features influence the translational potential?

Bart Cornelissen, Fijs W. B. van Leeuwen, Federico Caobelli, 2017, EJNMMI Radiopharmacy and Chemistry.

Scanning electron microscopy of femoral ossification in the human foetus.

J. Barbet, A. Pompidou, H. Copin, 1992, Bulletin de l'Association des anatomistes.

ARRONAX, a high intensity cyclotron in Nantes

Arnaud Guertin, Jean-François Chatal, Jacques Barbet, 2007 .

Equilibrium expert: an add-in to Microsoft Excel for multiple binding equilibrium simulations and parameter estimations.

Olivier Raguin, Anne Gruaz-Guyon, Jacques Barbet, 2002, Analytical biochemistry.

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

C. Bailly, C. Bodet-Milin, F. Kraeber-Bodéré, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Immuno-PET using anti-CEA bispecific antibody and 68 Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial.

Goldenberg, V. Rohmer, O. Couturier, 2016 .

Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT

C. Bailly, C. Bodet-Milin, F. Kraeber-Bodéré, 2018, Oncotarget.

Synthesis of new bivalent peptides for applications in the Affinity Enhancement System.

A. Ouadi, J. Chatal, J. Barbet, 2005, Bioconjugate chemistry.

Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

J. Chatal, J. Barbet, A. Gruaz-Guyon, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients

P. Moreau, F. Kraeber-Bodéré, J. Barbet, 2012, Tumor Biology.

(211)At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds.

J. Barbet, J. Pilmé, R. Maurice, 2016, European journal of medicinal chemistry.

213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

P. Moreau, J. Barbet, F. Bruchertseifer, 2013, The Journal of Nuclear Medicine.

Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.

J. Barbet, A. Gruaz-Guyon, D. Tourwé, 2009, Bioconjugate chemistry.

Intervertebral disc degeneration.

Jeffrey C. Lotz, J. Lotz, Rui-hai Zhou, 2004, Journal of occupational medicine. : official publication of the Industrial Medical Association.

Synthetic models related to DNA intercalating molecules: comparison between quinacrine and chloroquine in their ring-ring interaction with adenine and thymine

B. Roques, J. Barbet, J. Lhomme, 1982 .

[Fetal development and postnatal maturation of the longus colli muscle].

J. Barbet, M. Mayoux-Benhamou, M A Mayoux-Benhamou, 2001, Morphologie : bulletin de l'Association des anatomistes.

A novel protein immunoassay with predetermined specificity using monoclonal antibodies against tryptic fragments: application to HIV P24 antigen.

J. Barbet, M. Delaage, F. Jean, 1995, Journal of immunological methods.

Therapy for colon carcinoma xenografts with bispecific antibody‐targeted, iodine‐131‐labeled bivalent hapten

E. Gautherot, J. Barbet, E. Rouvier, 1997, Cancer.

Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

E. Brambilla, C. Brambilla, P. Brichon, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pretargeted radioimmunotherapy using131I-labelled bivalent hapten-bearing peptides

E. Gautherot, W. Rostène, J. Barbet, 1997, Letters in Peptide Science.

Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.

J. Benoit, F. Hindré, J. Chatal, 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens.

W. Rostène, J. Barbet, A. Gruaz-Guyon, 2000, Bioconjugate chemistry.

The Posterior Muscles of the Auricle : Anatomy and Surgical Applications

C. Vacher, J. Barbet, R. Bendrihem, 2015 .

Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery

J. Barbet, A. Faivre-Chauvet, J. Gestin, 2011, Journal of drug delivery.

A 140‐Kilodalton Protein Is Released from Cultured Astrocytes by Phosphatidylinositol Phospholipase C

A. Prochiantz, J. Barbet, C. Goridis, 1988, Journal of neurochemistry.

Nuclear medical imaging using β+γ coincidences from 44Sc radio-nuclide with liquid xenon as detection medium

Thomas Carlier, N. Servagent, Jacques Barbet, 2007 .

Does the Source of Laser Energy Influence the Coagulation of Chorionic Plate Vessels? Comparison of Nd:YAG and Diode Laser on an ex vivo Placental Model

Yves Ville, Jacky Nizard, Y. Ville, 2006, Fetal Diagnosis and Therapy.